| An EQ-5D-5L value set for England N Devlin, KK Shah, Y Feng, B Mulhern, B Van Hout Health Economics 27 (1), 7-22, 2018 | 1292 | 2018 |
| EuroQol protocols for time trade-off valuation of health outcomes M Oppe, K Rand-Hendriksen, K Shah, JM Ramos‐Goñi, N Luo Pharmacoeconomics 34, 993-1004, 2016 | 227 | 2016 |
| Severity of illness and priority setting in healthcare: a review of the literature KK Shah Health policy 93 (2-3), 77-84, 2009 | 201 | 2009 |
| Using QALYs in cancer: a review of the methodological limitations M Garau, KK Shah, AR Mason, Q Wang, A Towse, MF Drummond Pharmacoeconomics 29, 673-685, 2011 | 122 | 2011 |
| Valuing health at the end of life: a stated preference discrete choice experiment KK Shah, A Tsuchiya, AJ Wailoo Social science & medicine 124, 48-56, 2015 | 111 | 2015 |
| Comparing the UK EQ-5D-3L and English EQ-5D-5L value sets B Mulhern, Y Feng, K Shah, MF Janssen, M Herdman, B van Hout, ... Pharmacoeconomics 36, 699-713, 2018 | 104 | 2018 |
| International valuation protocol for the EQ-5D-Y-3L JM Ramos-Goñi, M Oppe, E Stolk, K Shah, S Kreimeier, O Rivero-Arias, ... Pharmacoeconomics 38 (7), 653-663, 2020 | 96 | 2020 |
| Utility values for health states in Ireland: a value set for the EQ-5D-5L A Hobbins, L Barry, D Kelleher, K Shah, N Devlin, JMR Goni, C O’Neill Pharmacoeconomics 36, 1345-1353, 2018 | 90 | 2018 |
| Valuation of EuroQol five-dimensional questionnaire, youth version (EQ-5D-Y) and EuroQol five-dimensional questionnaire, three-level version (EQ-5D-3L) health states: the … S Kreimeier, M Oppe, JM Ramos-Goñi, A Cole, N Devlin, M Herdman, ... Value in Health 21 (11), 1291-1298, 2018 | 82 | 2018 |
| New methods for modelling EQ‐5D‐5L value sets: An application to English data Y Feng, NJ Devlin, KK Shah, B Mulhern, B van Hout Health Economics 27 (1), 23-38, 2018 | 82 | 2018 |
| A comparison of alternative variants of the lead and lag time TTO N Devlin, K Buckingham, K Shah, A Tsuchiya, C Tilling, G Wilkinson, ... Health Economics 22 (5), 517-532, 2013 | 72 | 2013 |
| Valuing health at the end of life: an empirical study of public preferences KK Shah, A Tsuchiya, AJ Wailoo The European Journal of Health Economics 15, 389-399, 2014 | 68 | 2014 |
| NICE's social value judgements about equity in health and health care KK Shah, R Cookson, AJ Culyer, P Littlejohns Health Economics, Policy and Law 8 (2), 145-165, 2013 | 64 | 2013 |
| HTA methodology and value frameworks for evaluation and policy making for cell and gene therapies D Coyle, I Durand-Zaleski, J Farrington, L Garrison, ... The European Journal of Health Economics 21, 1421-1437, 2020 | 51 | 2020 |
| Multinational evidence of the applicability and robustness of discrete choice modeling for deriving EQ-5D-5L health-state values PFM Krabbe, NJ Devlin, EA Stolk, KK Shah, M Oppe, B van Hout, EH Quik, ... Medical Care 52 (11), 935-943, 2014 | 48 | 2014 |
| Is the aim of the English health care system to maximize QALYs? K Shah, C Praet, N Devlin, J Sussex, J Appleby, D Parkin Journal of Health Services Research & Policy 17 (3), 157-163, 2012 | 46* | 2012 |
| Valuing EQ-5D-Y-3L health states using a discrete choice experiment: do adult and adolescent preferences differ? DJ Mott, KK Shah, JM Ramos-Goñi, NJ Devlin, O Rivero-Arias Medical Decision Making 41 (5), 584-596, 2021 | 45 | 2021 |
| Views of the UK general public on important aspects of health not captured by EQ-5D KK Shah, B Mulhern, L Longworth, MF Janssen The Patient-Patient-Centered Outcomes Research 10, 701-709, 2017 | 44* | 2017 |
| An exploration of methods for obtaining 0= dead anchors for latent scale EQ-5D-Y values KK Shah, JM Ramos-Goñi, S Kreimeier, NJ Devlin The European Journal of Health Economics 21, 1091-1103, 2020 | 43 | 2020 |
| Using patient-reported outcome measures to estimate cost-effectiveness of hip replacements in English hospitals J Appleby, E Poteliakhoff, K Shah, N Devlin Journal of the Royal Society of Medicine 106 (8), 323-331, 2013 | 41 | 2013 |
